文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > in vivo-human breast carcinoma(MCF-7) and human prostate cancer (PC-3)
侵权投诉

in vivo-human breast carcinoma(MCF-7) and human prostate cancer (PC-3)

TH302在MCF-7和PC-3肿瘤模型中的抑瘤作用

IJC

International Journal of Cancer

Activityofthehypoxia-activatedpro-drugTH-302inhypoxicandperivascularregionsofsolidtumorsanditspotentialtoenhancetherapeuticeffectsofchemotherapy

JasdeepK.Saggar1andIanF.Tannock1,2*

12

DepartmentofMedicalBiophysics,UniversityofToronto,Toronto,ON,Canada

DivisionofMedicalOncologyandHematology,PrincessMargaretCancerCentre,Toronto,ON,Canada

Manychemotherapydrugshavepoortherapeuticactivityinregionsdistantfromtumorbloodvesselsbecauseofpoortissuepenetrationandlowcytotoxicactivityagainstslowly-proliferatingcells.Thehypoxia-activatedpro-drugTH-302mayhaveselectivetoxicityforhypoxicandneighboringcellsintumors.HerewecharacterizethespatialdistributionandabilityofTH-302toselectivelytargethypoxicregionsandcomplementtheeffectofdoxorubicinanddocetaxelbymodifyingbiomarkerdis-tribution.AthymicnudemicebearinghumanbreastMCF-7orprostatePC-3tumorsweretreatedwithdoxorubicinordocetaxelrespectivelyandTH-302aloneorincombination.BiomarkersofdrugeffectincludingcH2aX(amarkerofDNAdamage),

cleavedcaspase-3or-6(markersofapoptosis)andreductioninKi-67(amarkerofcellproliferation)werequantifiedintumorsectionsinrelationtofunctionalbloodvessels(recognizedbyDiOC7)andhypoxia(recognizedbyEF5)usingimmunohisto-chemistry.cH2aXexpressionat10minandcleavedcaspase-3or-6at24hrafterdoxorubicinordocetaxeldecreasedwithincreasingdistancefromtumorbloodvessels,withminimalexpressioninhypoxicregions;maximumreductioninKi67levelswasobservedinregionsclosesttovasculatureat24hr.TH-302inducedmaximalcelldamageinhypoxicandneighboringregions,butwasalsoactiveintumorregionsclosertobloodvessels.TH-302given4hrbeforedoxorubicinordocetaxelincreasedDNAdamageandapoptosisthroughoutthetumorcomparedtochemotherapyalone.Whengivenwithdoxorubicinordocetaxel,TH-302complementsandenhancesanticancereffectsinbothperivascularandhypoxicregionsbutalsoincreasestoxicity.

CancerTherapy

Mostsolidtumorscontainhypoxicregions,andhypoxiccellsmaybeimportantinlimitingtheeffectsofbothradiotherapyandchemotherapy.Thepresenceofoxygenincreasestheeffectsofradiationviaincreased xationoffreeradicalsonDNAstrandsandhypoxiccellsarerelativelyradio-resist-ant.1,2Hypoxiccellsintumorsarede cientinothernutrientsandareslowlyornon-proliferating:theymaybesparedbychemotherapybecauseofpoorpenetrationofdrugstohypoxictumorregions,3andbecausemostanticancerdrugsaremoreeffectiveagainstrapidlyproliferatingcells.Inaddi-Keywords:drugdistribution,pharmacodynamicmarkers,tumormicroenvironment,drugpenetration,hypoxia-activatedpro-drug,TH-302

*Dr.IanF.TannockhasreceivedresearchfundingfromThresholdPharmaceuticals.

Grantsponsor:CanadianInstitutesofHealthResearch(CIHR)andThresholdPharmaceuticalstoDr.TannockandaCIHRBanting&Bestdoctoralstudentship(toJ.K.S.)DOI:10.1002/ijc.28595

History:Received22Aug2013;Accepted25Oct2013;Online8Nov2013

Correspondenceto:IanF.Tannock,PrincessMargaretCancerCentre,Suite5-208,610UniversityAvenue,Toronto,OntarioM5G2M9,Canada,Tel.:1416-946-2245,Fax:1416-946-4563,E-mail:ian.tannock@uhn.cationtotheirradio-resistance,thepresenceofhypoxialeadstoamoreaggressivephenotypeduetotheexpressionofpro-survivalgenes(includingmutatedp53),increasedlevelsofproteinsfavoringanepithelial-to-mesenchymaltransition,increasedmetastasis,angiogenesisandinhibitionofapopto-sis.4Forthesereasons,hypoxiccellsmaybeanimportantcauseoftreatmentfailureinsolidtumorsandmayrepopu-latethetumor.Therapiesthattargethypoxictumorcellsthereforehavepotentialtoaugmenttheeffectsofradiother-apyandchemotherapy.1Also,hypoxiccellsoccurrarelyinnormaltissues,sothattargetingthemmightoffertumorselectivity.Hypoxia-targetedtherapiessuchasgenetherapy(usingapromoterhighlyresponsivetoHypoxiaInducibleFactor-1[HIF-1]),recombinantanaerobicbacteria(whosesporesactivateinnecroticcentersoftumorsandkilltumortissue)andhypoxia-activatedpro-drugs(HAPs)areallunderinvestigation.1,5

HAPsareadministeredinaninactiveformandarereducedtotheiractivemetaboliteswithinhypoxicregionsoftumors.1Onceactivatedtheymaydiffusetoactagainstcellsinneighboringtumorregions(“thebystandereffect”).The rstHAPtoundergoclinicaltestingwastirapazamine;andalthoughactivityagainsthypoxiccellsinhumantumorscouldbeshown,6largerandomizedtrialsevaluatingtirapaz-amineincombinationwithradiotherapyorchemotherapydidnotestablishtherapeuticbene t.7–9Tirapazaminehad

C2013UICCInt.J.Cancer:134,2726–2734(2014)V

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email